partículas de n-(5-ciano-4-((2-metoxietil)amino)piridin-2-il)-7-formil-6-((4-metil-2-oxopiperazin-1-il)metil)-3,4-di-hidro-1,8-naftiridina-1(2h)-carboxamida

a presente invenção refere-se a partículas de n-(5-ciano-4-((2-metoxietil)amino)piridin-2-il)-7-formil-6-((4-metil-2-oxopiperazin-1-il) metil)-3,4-di-hidro-1,8-naftiridina-1(2h)-carboxamida, a um processo de preparar as referidas partículas, a composições farmacêuticas compreendendo as referidas par...

Full description

Saved in:
Bibliographic Details
Main Authors LV LIAO, BO HAN, XIANGLIN ZHAO, ROBIN ALEC FAIRHURST, JULIE MARTZ, THOMAS KNOEPFEL, JING XIONG, FRANCK MALLET, CATHERINE LEBLANC, ROBERT MAH, PASCAL FURET, NICOLE BUSCHMANN, CAN WANG
Format Patent
LanguagePortuguese
Published 10.04.2018
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:a presente invenção refere-se a partículas de n-(5-ciano-4-((2-metoxietil)amino)piridin-2-il)-7-formil-6-((4-metil-2-oxopiperazin-1-il) metil)-3,4-di-hidro-1,8-naftiridina-1(2h)-carboxamida, a um processo de preparar as referidas partículas, a composições farmacêuticas compreendendo as referidas partículas e a método de tratar cânceres usando as referidas composições farmacêuticas. The present invention relates to particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide, to a process of making said particles, to pharmaceutical compositions comprising said particles and to method of treating cancers using said pharmaceutical compositions.
Bibliography:Application Number: BR20171116991